Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Asystole with electroconvulsive therapy

K R Kaufman1

  • 1UCLA School of Medicine.

Journal of Internal Medicine
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Labetalol, a beta-blocker, can rarely cause cardiac asystole after electroconvulsive therapy (ECT). This case highlights potential cardiac risks associated with this common treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A national strategy for a canadian limb loss and limb difference registry.

Canadian prosthetics & orthotics journal·2026
Same author

Developing and Establishing Biomechanical Variables as Risk Biomarkers for Preventable Gait-Related Falls and Assessment of Intervention Effectiveness.

Frontiers in sports and active living·2021
Same author

Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.

Journal of clinical pharmacy and therapeutics·2016
Same author

Step detection using multi- versus single tri-axial accelerometer-based systems.

Physiological measurement·2015
Same author

Dynamic balance assessment during gait in spinal pathologies - a literature review.

Orthopaedics & traumatology, surgery & research : OTSR·2015
Same author

Use of a Poroelastic Model to Predict Intramuscular Pressure.

Poromechanics V : proceedings of the fifth Biot Conference on Poromechanics, July 10-12, 2013, Vienna, Austria. Biot Conference on Poromechanics (5th : 2013 : Vienna, Austria)·2014
Same journal

Social jet lag is associated with incident cardiovascular disease independent of sleep duration and cardiac genetic risk.

Journal of internal medicine·2026
Same journal

Multicenter validation of a severity index model for predicting postoperative acute kidney injury.

Journal of internal medicine·2026
Same journal

The changing epidemiology of human type 2 diabetes-associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities.

Journal of internal medicine·2026
Same journal

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Journal of internal medicine·2026
Same journal

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
Same journal

Regarding: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology
  • Neuroscience

Background:

  • Electroconvulsive therapy (ECT) is a widely used psychiatric treatment.
  • Labetalol is a combined alpha- and beta-adrenergic blocker often used perioperatively.
  • Cardiac complications, though rare, can occur during or after ECT.

Observation:

  • A rare case of asystole (cardiac arrest) is reported.
  • The complication occurred following electroconvulsive therapy (ECT).
  • The patient was receiving labetalol, a beta-adrenergic blocking agent.

Findings:

  • Beta-adrenergic blockade by labetalol may potentiate or unmask underlying cardiac vulnerabilities during ECT.
  • The specific cardiac mechanisms leading to asystole in this context are explored.

Related Experiment Videos

  • A review of 33 references supports the discussion of potential cardiac pathways.

    • Implications:

    • Clinicians should be aware of the potential for severe bradyarrhythmias or asystole when using labetalol in patients undergoing ECT.
    • Careful cardiac monitoring is warranted in patients receiving beta-blockers during ECT.
    • Further research into the electrophysiologic interactions between labetalol and ECT may be beneficial.